DMRA | Damora TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

Damora Therapeutics (DMRA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2026.

Price sits between the 50 and the 200 on the 4-hour.

Timeframe summary

Daily

No daily data

Weekly

No weekly data

4-hour as of 3 Nov 16:00 ET

Price
between the two $22.08 vs 50 $20.58 / 200 $25.74
Projection
No cross projected
Test
No active test
Last cross
Death cross 25 Sep 2026 ยท projected 27 bars out

Cross history

1
cross on record since 2026
0 golden1 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
25 Sep 2026Death4-hour27 bars outNot tested

About DMRA

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$9.7M
4-hour coverageYes, since Mar 2026
History on recordSince 2026
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.